期刊文献+

冠状动脉内支架置入术后再狭窄与尿酸的关系 被引量:38

The relationship between serum uric acid and intracoronary in-stent restenosis
原文传递
导出
摘要 目的 :探讨冠状动脉 (冠脉 )内支架置入术后再狭窄与血清尿酸的关系。方法 :2 13例冠脉内支架术后患者因胸痛复发或医生动员行冠脉造影随访 ,以支架置入段内径狭窄≥ 5 0 %为再狭窄。记录这些患者的冠心病易患因素 ,并测定血清尿酸浓度。结果 :2 13例患者共 2 5 7处病变所置入的支架中 ,支架内再狭窄 87例 (138处病变 ) ,其血清尿酸浓度明显高于无再狭窄患者 (P <0 .0 5 )。多因素Logistic逐步回归分析显示 :高尿酸血症是支架内再狭窄的独立危险因素 (OR =1.15 )。结论 :高尿酸血症与冠脉内支架再狭窄明显相关 。 Objective:To assess the relationship between serum concentration of uric acid and intracoronary in stent restenosis. Methods: Follow up of coronary angiography was performed in 213 patients due to recurrence of chest pain or doctor's advise. In stent restenosis was defined as luminal diameter narrowing of intracoronary stent by 50% or greater. Risk factors for coronary artery disease were recorded and serum concentration of uric acid was measured. Results: In 213 patients, 257 coronary stents were implanted. In stent restenosis was occurred in 138 lesions of 87 patients. Serum concentration of uric acid in in stent restenosis group was much higher than that in non in stent restenosis group (P< 0.05 ). Multivariate logistic regression analysis revealed that hyperuricemia was an independent risk factor of in stent restenosis (OR= 1.15 ).Conclusion: There is a close relationship between serum uric acid and in stent restenosis. The occurrence of in stent restenosis may be reduced by lowering serum concentration of uric acid.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2002年第8期359-360,共2页 Journal of Clinical Cardiology
关键词 冠状动脉疾病 支架置入术 再狭窄 尿酸 Coronary disease Stents Restenosis Uric acid
  • 相关文献

参考文献8

  • 1Fischman D, Leon M,Bain D, et al.A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary disease. N Engl J Med, 1994,331:496-501.
  • 2Savage M P, Fischman D L, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent restenosis study[STRESS] investigators. J Am Coll Cardiol, 1998,31:307-311.
  • 3Kastrati S, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997,30:1428-1436.
  • 4郭静萱,毛节明,郭丽君,张福春,李海燕,温尚煜,赵一鸣,陈明哲.冠状动脉内支架再狭窄的多因素回归分析[J].中华心血管病杂志,1998,26(6):423-425. 被引量:33
  • 5Erbel R, Haude M, Hopp H W, et al. Restenosis stent(REST) study: Randomized trial comparing stenting and balloon angioplasty for treatment of restenosis after balloon angioplasty(abstract). J Am Coll Cardiol,1996,27(Suppl A):139-143.
  • 6Barbir M, Hunt B J, Galloway D, et al.A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting. Clin Cardiol, 1994,17:59-65.
  • 7Loscalzo J, Weinfeld M, Fless G M, et al. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis,1990,10:240-245.
  • 8Fang J, Alderman M H. Serum uric acid and cardiovascular mortality. The NHANESI epidemiologic follow-up study, 1971-1992. JAMA, 2000,283:2404-2410.

二级参考文献1

  • 1郭静萱,中华心血管病杂志,1996年,24卷,1页

共引文献32

同被引文献580

引证文献38

二级引证文献338

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部